It showed that the percentage of CD86+CD11b+ cells (M1 macrophages) was decreased in MS and MR cells, and the percentage was significantly lower in MR cells than in MS cells (HGC27: p = 0.032; MKN45: p = 0.028). Here, CD86 is linked to myeloid sarcoma.